{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:45:13Z","timestamp":1786653913733,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300277"],"award-info":[{"award-number":["82300277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["B2025610"],"award-info":[{"award-number":["B2025610"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["B2023012"],"award-info":[{"award-number":["B2023012"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.numecd.2026.104752","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T16:31:42Z","timestamp":1776011502000},"page":"104752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic dysfunction-associated fatty liver disease and cardiac remodeling in non-ischemic dilated cardiomyopathy"],"prefix":"10.1016","volume":"36","author":[{"given":"Jinjie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4545-6153","authenticated-orcid":false,"given":"Yupeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.numecd.2026.104752_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/CM9.0000000000002688","article-title":"Circulating biomarker- and magnetic resonance-based nomogram predicting long-term outcomes in dilated cardiomyopathy","volume":"137","author":"Liu","year":"2024","journal-title":"Chin Med J (Engl Ed)"},{"key":"10.1016\/j.numecd.2026.104752_bib2","article-title":"Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease","author":"Targher","year":"2021","journal-title":"Trends Endocrinol Metabol"},{"issue":"4","key":"10.1016\/j.numecd.2026.104752_bib3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.numecd.2026.104752_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221139650","article-title":"Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease","volume":"13","author":"Kaya","year":"2022","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.numecd.2026.104752_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-022-01697-0","article-title":"Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention","volume":"21","author":"Zhou","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2026.104752_bib6","doi-asserted-by":"crossref","unstructured":"Kaya E, Yilmaz Y. Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver. J Clin Transl Hepatol. 10(2):329.","DOI":"10.14218\/JCTH.2021.00178"},{"key":"10.1016\/j.numecd.2026.104752_bib7","doi-asserted-by":"crossref","unstructured":"Mantovani A, Csermely A, Petracca G, et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 6(11):903-913. doi:10.1016\/S2468-1253(21)00308-3.","DOI":"10.1016\/S2468-1253(21)00308-3"},{"issue":"3","key":"10.1016\/j.numecd.2026.104752_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.numecd.2026.104752_bib9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jhep.2021.05.008","article-title":"Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease","volume":"75","author":"Younes","year":"2021","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.numecd.2026.104752_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/00365521.2019.1583366","article-title":"Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD)","volume":"54","author":"\u00d6nnerhag","year":"2019","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1016\/j.numecd.2026.104752_bib11","article-title":"Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease","volume":"17","author":"Fotbolcu","year":"2010","journal-title":"Cardiol J"},{"issue":"9","key":"10.1016\/j.numecd.2026.104752_bib12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.numecd.2008.12.007","article-title":"Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension","volume":"19","author":"Fallo","year":"2009","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.numecd.2026.104752_bib13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.numecd.2026.104752_bib14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/oby.21879","article-title":"Nonalcoholic steatohepatitis is associated with cardiac remodeling and dysfunction","volume":"25","author":"Simon","year":"2017","journal-title":"Obesity"},{"issue":"9","key":"10.1016\/j.numecd.2026.104752_bib15","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort","volume":"71","author":"Simon","year":"2022","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.numecd.2026.104752_bib16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/cells9030567","article-title":"Relationship between heart disease and liver disease: a two-way street","volume":"9","author":"El Hadi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.numecd.2026.104752_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2019.00202","article-title":"Cardiovascular risk in fatty liver disease: the liver-heart axis\u2014literature review","volume":"6","author":"Ismaiel","year":"2019","journal-title":"Front Med"},{"issue":"10","key":"10.1016\/j.numecd.2026.104752_bib18","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.numecd.2026.104752_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead082","article-title":"Prognostic implication of liver fibrosis scores in patients with non-ischemic dilated cardiomyopathy","volume":"3","author":"Liu","year":"2023","journal-title":"Eur Heart J Open"},{"issue":"1","key":"10.1016\/j.numecd.2026.104752_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.numecd.2026.104752_bib21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s12072-021-10252-0","article-title":"Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case\u2013control study","volume":"15","author":"Liu","year":"2021","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.numecd.2026.104752_bib22","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"Day CP the NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.numecd.2026.104752_bib23","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s10620-016-4040-6","article-title":"Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease","volume":"61","author":"Mantovani","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.numecd.2026.104752_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41569-020-0433-5","article-title":"Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications","volume":"18","author":"Matyas","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2026.104752_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.748173","article-title":"Correlation between liver stiffness and diastolic function, left ventricular hypertrophy, and right cardiac function in patients with ejection fraction preserved heart failure","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.numecd.2026.104752_bib26","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/ehf2.13317","article-title":"Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction","volume":"8","author":"Nakashima","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"11","key":"10.1016\/j.numecd.2026.104752_bib27","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCRESAHA.125.325492","article-title":"Decoding the liver-heart axis in cardiometabolic diseases","volume":"136","author":"Capone","year":"2025","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.numecd.2026.104752_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/biom15020163","article-title":"Metabolic dysfunction-associated steatotic liver disease: pathogenetic links to cardiovascular risk","volume":"15","author":"Ionescu","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.numecd.2026.104752_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1573841","article-title":"Role of metabolic dysfunction-associated fatty liver disease in atrial fibrillation and heart failure: molecular and clinical aspects","volume":"12","author":"Cheung","year":"2025","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.numecd.2026.104752_bib30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/ehjci\/jeab059","article-title":"Prognostic value and reversibility of liver stiffness in patients undergoing tricuspid annuloplasty","volume":"23","author":"Chen","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.numecd.2026.104752_bib31","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.cgh.2024.03.045","article-title":"Liver fibrosis assessed via noninvasive tests is associated with incident heart failure in a general population cohort","volume":"22","author":"Hydes","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2026.104752_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1574385","article-title":"Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective","volume":"16","author":"Zeng","year":"2025","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.numecd.2026.104752_bib33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/med4.70014","article-title":"Enhancing heart health: expanding the use of SGLT2 inhibitors in cardiovascular disease","volume":"3","author":"Mubeen","year":"2025","journal-title":"Med Adv"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326002140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326002140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:54:37Z","timestamp":1786650877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475326002140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0939475326002140"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104752","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic dysfunction-associated fatty liver disease and cardiac remodeling in non-ischemic dilated cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104752"}}